Clinical Trial Update: The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating metformin’s impact on functional capacity in individuals with peripheral arterial disease-related intermittent claudication …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Baker Heart and Diabetes Institute | Conditions: Peripheral Arterial Disease, Intermittent Claudication | Phase 4 | Status: TERMINATED